Watch the ABC Live TV interview of A/Prof Dr Karin Ried with Andrew Geoghegen – discussing the new prostate cancer test and the second phase of the NIIM research study.
With over 3,300 Australian men dying from Prostate Cancer each year, NIIM has been searching for a more reliable and accurate way to diagnose the disease.
As an extension of our ISET-CTC Test, which is exclusively available in Australia at NIIM, we have used PSA (Prostate) markers to develop a test which has been found a true positive rate of 99% and true negative rate of 97%.
Find out more about NIIM Prostate Cancer Screening Study including the criteria and how to participate in NIIM’s population study for the ISET®-CTC Test for prostate cancer
View the published research:
Ried, K. et al. New Screening Test Improves Detection of Prostate Cancer Using Circulating Tumor Cells and Prostate-Specific Markers. Frontiers in Oncology.
Access via https://pubmed.ncbi.nlm.nih.gov/32391268/
